Lv6
1750 积分 2023-11-04 加入
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
21天前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1个月前
已完结
中国慢性肾脏病筛查、诊断及治疗临床实践指南 2026版
2个月前
已完结
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
2个月前
已完结
Lower urinary albumin‐to‐creatinine ratio predicted all‐cause and cardiovascular mortality in Chinese population with diabetes and prediabetes—The Shanghai Changfeng cohort study
2个月前
已完结
Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
2个月前
已完结
Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes
2个月前
已完结
Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk
2个月前
已完结
皖公网安备34019202002308
